Global Preventive Medicine Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Specialty Areas;

Aerospace Medicine, Occupational Medicine and Public Health and General Preventive Medicine.

By Distribution Channels;

Hospitals, Diagnostic Centers and Employers.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn481814759 Published Date: June, 2024 Updated Date: July, 2024

Introduction

Global Preventive Medicine Market (USD Million), 2020 - 2030

In the year 2023, the Global Preventive Medicine Market was valued at USD 372,548.95 million. The size of this market is expected to increase to USD 509,028.82 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 4.6%.

The growth of the preventive medicine market is primarily driven by the escalating prevalence of lifestyle-associated and chronic diseases, a trend underscored by forecasts from reputable sources like the National Institute of Health (NIH). As per projections, a significant portion of the U.S. adult population aged 50 and above is expected to contend with at least one chronic condition by 2035. This mounting health concern has spurred a surge in interest in preventive healthcare, bolstered by extensive awareness campaigns facilitated by governmental initiatives.

Legislative mandates such as the Patient Protection and Affordable Care Act, commonly known as Obamacare, have catalyzed the integration of preventive healthcare into insurance coverage without additional charges. Private insurers have also redirected their focus towards this burgeoning market, recognizing its immense potential. From the consumers' standpoint, preventive healthcare offers the promise of a higher quality of life and reduced stress, with investments in insurance policies or services often proving more cost-effective compared to treating diseases in hospital settings.

Furthermore, the proliferation of diagnostic devices capable of detecting asymptomatic diseases early on contributes significantly to market growth. This trend aligns with a notable rise in health insurance coverage in the United States over the past decade, as reported by Statista. While preventive healthcare serves a broad demographic, it particularly addresses the needs of the geriatric population, which faces heightened susceptibility to chronic and cardiovascular ailments. The aging global demographic, underscored by forecasts from the World Health Organization (WHO), further accentuates the positive impact on market growth, as the elderly population is projected to expand significantly in the coming years.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Specialty Areas
    2. Market Snapshot, By Distribution Channels
    3. Market Snapshot, By Region
  4. Global Preventive Medicine Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising burden of chronic diseases
        2. Increasing healthcare costs
        3. Growing awareness of preventive healthcare
      2. Restraints
        1. Lack of reimbursement
        2. Limited access to healthcare
        3. Public perception
      3. Opportunities
        1. Expansion of preventive healthcare services
        2. Focus on early detection
        3. Integration with wellness programs
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Global Preventive Medicine Market, By Specialty Areas, 2020 - 2030 (USD Million)
      1. Aerospace Medicine
      2. Occupational Medicine
      3. Public Health and General Preventive Medicine
    2. Global Preventive Medicine Market, By Distribution Channels, 2020 - 2030 (USD Million)
      1. Hospitals
      2. Diagnostic Centers
      3. Employers
    3. Global Preventive Medicine Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Novo Nordisk
      2. Eli Lilly
      3. Quanterix
      4. Aetna Inc
      5. Preventive Medical Health Care Co., LTD
      6. Cancer Prevention Pharmaceuticals, Inc
      7. Phoenix Medicine
  7. Analyst Views
  8. Future Outlook of the Market